Written by experts in the field, this book discusses diverse modes of binding of antibiotics and drugs to DNA, emphasizing matters that are important or promising for cancer treatment. Chapters discuss established agents like actinomycin D but also look at novel drugs with strong potential in chemotherapy such as new topoisomerase inhibitors, telomerase inhibitors, peptide nucleic acids and triple helix-forming oligonucleotides.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
The binding of antibiotics and drugs to DNA is a fast developing area of research with important applications in medicine, particularly the treatment of cancer. Sequence-specific DNA Binding Agents uniquely discusses key aspects of this topic, providing a novel perspective on the subject.
Written by experts in the field, this book discusses diverse modes of binding of antibiotics and drugs to DNA, emphasising matters that are important or promising for cancer treatment. Chapters discuss established agents like actinomycin D but also look at novel drugs with strong potential in chemotherapy such as new topoisomerase inhibitors, telomerase inhibitors, peptide nucleic acids and triple helix-forming oligonucleotides. There are also sections discussing methodological advances including computational methods, slow kinetics, melting curve analysis and approaches to medicinal chemistry. Finally there is a section on RNA structure and its potential as a drug target.
The book is ideal for researchers in industry and academia who require a comprehensive source of reference to this rapidly expanding subject.
Chapter 1 DNA Recognition by Triple Helix Formation David A. Rusling, Tom Brown and Keith R. Fox, 1,
Chapter 2 Interfacial Inhibitors of Human Topoisomerase I Christophe Marchand and Yves Pommier, 29,
Chapter 3 Diversity of Topoisomerase I Inhibitors for Cancer Chemotherapy Nathalie Dias and Christian Bailly, 44,
Chapter 4 Slow DNA Binding L. Marcus Wilhelmsson, Per Lincoln and Bengt Nordén, 69,
Chapter 5 DNA Gene Targeting using Peptide Nucleic Acid (PNA) Peter E. Nielsen, 96,
Chapter 6 Actinomycin D: Sixty Years of Progress in Characterizing a Sequence-Selective DNA-Binding Agent David E. Graves, 109,
Chapter 7 Thermal Denaturation of Drug–DNA Complexes: Tools and Tricks Jonathan B. Chaires and Xiaochun Shi, 130,
Chapter 8 Computer Simulations of Drug–DNA interactions: A Personal Journey Federico Gago, 152,
Chapter 9 The Discovery of G-Quadruplex Telomere Targeting Drugs Stephen Neidle, 190,
Chapter 10 The Mechanism of Action of Telomestatin, a G-Quadruplex-Interactive Compound Daekyu Sun and Laurence H. Hurley, 207,
Chapter 11 Structural Features of the Specific Interactions between Nucleic Acids and Small Organic Molecules Alexander Serganov and Dinshaw J. Patel, 233,
Subject Index, 253,
DNA Recognition by Triple Helix Formation
DAVID A. RUSLING, TOM BROWN AND KEITH R. FOX
1.1 Introduction
Oligonucleotides can bind in the major groove of double-stranded DNA by forming hydrogen bonds with exposed groups on the base pairs, generating a triple-helical structure (Figure 1A). This was first demonstrated nearly 50 years ago by Rich and co-workers by mixing the synthetic polyribonucleotides polyU and polyA in a 2:1 ratio. Further studies showed that polyC and polyG can generate a similar structure under conditions of low pH and a variety of DNA and RNA triple-stranded structures have since been identified.
Since these complexes form in a sequence-specific fashion they can be used to target unique sequences. By knowing the rules that govern triplex formation, it should be possible to design oligonucleotides to interact with any desired DNA sequence. The formation of intermolecular triple-helical DNA therefore has a number of applications including inhibition of gene transcription, site-directed mutagenesis, and various biotechnological applications.
1.1.1 Triplets and Triplex Motifs
Triplex-forming oligonucleotides bind in the DNA major groove and make specific contacts with the purine strand of the duplex. The binding can be either parallel or antiparallel to the target strand, depending on the base composition of the oligonucleotide.
Pyrimidine-rich oligonucleotides bind under low pH conditions in a parallel orientation to the purine strand of the target duplex, with T and protonated C forming Hoogsteen hydrogen bonds with AT and GC base pairs, respectively. This generates the base triplets T.AT and C+.GC as shown in Figure 1B. (The notation X.ZY refers to a triplet in which the third-strand base X interacts with the duplex base pair ZY, forming hydrogen bonds to base Z). These triplets are isomorphic, that is if the C-1' atoms of their Watson-Crick base pairs are superimposed, the positions of the C-1' atoms of the third strand are almost identical. This minimizes backbone distortion of both the third strand and duplex between adjacent triplets. It is also possible to form a G.GC triplet within this motif, though this is not isomorphic with T.AT and C+.GC (Figure 1B (iii)). Most of this chapter will concentrate on the parallel motif.
Purine-rich oligonucleotides bind in an antiparallel orientation to the purine strand of the target duplex, with A and G forming reverse-Hoogsteen hydrogen bonds with AT and GC base pairs respectively, generating A.AT and G.GC triplets (see Figure 1C). In contrast to the parallel triplets, A.AT and G.GC triplets are not isomorphic, leading to structural distortions at junctions between each triplet. As a consequence of this and other factors, the antiparallel motif is often less stable than the parallel motif. T.AT triplets can also adopt an antiparallel orientation.
Since G.GC and T.AT triplets can be formed in both the parallel and antiparallel motifs GT-containing oligonucleotides can be designed to bind in either orientation, parallel or antiparallel. The backbone distortion imposed by the non-isomorphic nature of these two triplets means that the most stable orientation is dependent on the number of GpT and TpG steps.
Triplex formation in the parallel motif suffers from the requirement for low pH, which is necessary for protonation of cytosine at N3. Without protonation the C.GC triplet only contains one hydrogen bond between the exocyclic N4 of cytosine and 6-keto group of guanine. The pKa of cytosine is around 4.5, though this is increased on triplex formation, and is higher in the centre than the termini of a triplex. Runs of contiguous cytosine residues are destabilizing as they decrease the pKa. A large number of cytosine analogues have been prepared to overcome this problem and are described in a later section.
Several reports have suggested that C+.GC is more stable than T.AT. This is attributed to electrostatic interactions between the positive charge of cytosine and the negatively charged phosphodiester backbone and/or favourable stacking interactions between the charged base and the π-stack.
1.2 Strategies to Increase Triplex Stability
1.2.1 Sugar Modifications
The affinity of a third strand for its target is affected by its ability to adopt N- or S-type conformations, since the former require less distortion of the duplex purine strand upon triplex formation. This explains why RNA TFOs have a higher affinity for duplex DNA than those composed of DNA. Oligonucleotide modifications that favour N-type sugars are therefore expected to produce more stable triplexes and some examples are shown in Figure 2. The addition of an electronegative group at the 2'-position of the sugar, as in RNA, strongly favours the N-type sugar pucker due to the gauche effect and the 2'-O-methyl modification (Figure 2a) enhances triplex stability. NMR studies have confirmed that the 2'-methoxy group increases triplex stability by reducing the distortion of the duplex purine strand and enhancing the rigidity of the triplex.
Other modifications can also be used to restrict the sugar pucker and reduce the rotational freedom of the sugar phosphate backbone. The best characterized of these modifications is locked nucleic acid (LNA), which is also known as bridged nucleic acid (BNA), in which a 2'-O,4'-C methylene bridge is used to constrain the sugar to N-type (Figure 2b). This modification was developed independently by the Wengel and Imanishi groups for use in antisense or antigene applications, respectively. TFOs that contain LNA residues every 2-3 nucleotides are markedly more stable than their unmodified counterparts. Two further derivatives have also been developed from this. ENA contains an additional carbon in the bridge and unlike LNA can be fully substituted into TFOs (Figure 2c). In addition, 3'-amino-2',4'-LNA combines the LNA sugar with the N3'-P5' modification (considered below), though triplexes with this analogue are no more stable than those formed with LNA.
The bicyclo and tricyclo...
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. pp. xi + 258 Illus. Artikel-Nr. 7547655
Anzahl: 4 verfügbar
Anbieter: Phatpocket Limited, Waltham Abbey, HERTS, Vereinigtes Königreich
Zustand: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions. Artikel-Nr. Z1-F-054-00836
Anzahl: 2 verfügbar
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. Brand New. Soft Cover International Edition. Different ISBN and Cover Image. Priced lower than the standard editions which is usually intended to make them more affordable for students abroad. The core content of the book is generally the same as the standard edition. The country selling restrictions may be printed on the book but is no problem for the self-use. This Item maybe shipped from US or any other country as we have multiple locations worldwide. Artikel-Nr. ABNR-78493
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Artikel-Nr. ABNR-4646
Anbieter: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Deutschland
25 cm. 1 vol. (XI-258 p.) ill. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. RSC biomolecular sciences. Sprache: Englisch. Artikel-Nr. 5341MB
Anzahl: 1 verfügbar
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Artikel-Nr. ABNR-205690
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Artikel-Nr. ABNR-33190
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Artikel-Nr. ABNR-194355
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Artikel-Nr. ABNR-142652
Anbieter: moluna, Greven, Deutschland
Gebunden. Zustand: New. This book discusses diverse modes of binding of antibiotics and drugs to DNA, emphasising matters that are important or promising for cancer treatment.InhaltsverzeichnisChapter 1: DNA recognition by triple helix formation Chapter 2:. Artikel-Nr. 37507794
Anzahl: 1 verfügbar